FindMyKOL

Ralph Binder, MD

Basic profile

Pulmonary Disease

ORCIDNone on fileNPI↗
✓ Itemized record
RegionEastchester, NY · NortheastSpecialtyPulmonary DiseaseFocusRespiratory
Last active 2021FindMyKOL type: RegionalLatest publication2009Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ralph Binder is a Respiratory physician. OpenAlex indexes 8 publications with 477 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
8publications

Distinct works indexed by OpenAlex.

477citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    37.1%
    Statin10.4%
    Atorvastatin Calcium62%Rosuvastatin Calcium27%Simvastatin11%
    Part D<11 patients
    Calcium channel blocker6.7%
    Amlodipine Besylate82%Diltiazem 24hr Er (Cd)18%
    Part D<11 patients

    + 7 more classes in this area

  • Respiratory

    27.3%
    Corticosteroid12.5%
    Breo Ellipta26%Symbicort18%Flovent Hfa13%Qvar Redihaler10%Fluticasone Propionate9%Pulmicort Flexhaler9%Trelegy Ellipta8%Arnuity Ellipta7%
    Part D<11 patients
    beta2-Adrenergic Agonist6.2%
    Albuterol Sulfate Hfa73%Serevent Diskus27%
    Part D≥33 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    19.5%
    Proton pump inhibitor5.4%
    Omeprazole78%Pantoprazole Sodium22%
    Part D≥39 patients
    Corticosteroid4.6%
    Prednisone100%
    Part D≥42 patients

    + 4 more classes in this area

Where care is delivered (Part B), 20210% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”